发明申请
US20080039470A1 Acylaminoheteroaryl hepatitis C virus protease inhibitors 有权
酰氨基杂芳基丙型肝炎病毒蛋白酶抑制剂

Acylaminoheteroaryl hepatitis C virus protease inhibitors
摘要:
The present invention discloses compounds of formulae I and II, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
公开/授权文献
信息查询
0/0